Contact us for an analyst brief to understand the analysis and the market scenario; our team will help you create a revenue impact solution to achieve your desired goal. An increase in the usage of natural killer cells for the treatment of infectious diseases is the major driver that propelled the market's demand in the forecast period. Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 43.0% during the forecast period of 2022 to 2029.